301358:SZSEHunan Yuneng New Energy Battery Material Co., Ltd. Class A Analysis
Data as of 2026-06-20 - not real-time
CN¥76.08
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at CNY 76.08, which sits below both the 20‑day SMA (78.77) and the 50‑day SMA (85.28), indicating a short‑term price weakness, while the RSI of 43 and a modest bullish MACD histogram suggest limited upside momentum at present. Valuation metrics are attractive: the trailing P/E of 22.9 is well under the industry average of 31.4 and the forward P/E of 14.6 points to significant upside potential, reinforced by an analyst consensus target median of CNY 125.65 (≈59% upside).
On the fundamentals side, revenue has more than doubled (growth factor 1.213) and the company enjoys a low dividend payout ratio (4.7%), making the 0.47% yield sustainable despite modest margins. However, negative operating cash flow, a sizable debt load (debt‑to‑equity 67%), and high 30‑day volatility (≈55%) raise concerns about financial stability and price swings.
On the fundamentals side, revenue has more than doubled (growth factor 1.213) and the company enjoys a low dividend payout ratio (4.7%), making the 0.47% yield sustainable despite modest margins. However, negative operating cash flow, a sizable debt load (debt‑to‑equity 67%), and high 30‑day volatility (≈55%) raise concerns about financial stability and price swings.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below short‑term moving averages
- Neutral RSI and modest bullish MACD signal
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to industry P/E
- Strong forward earnings outlook (forward P/E 14.6)
- Analyst price target indicating ~60% upside
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Long‑term demand growth for lithium‑ion battery cathodes
- Sustainable dividend despite low payout
- Concerns over negative cash flow and high debt
Key Metrics & Analysis
Financial Health
Revenue Growth121.30%
Profit Margin5.93%
P/E Ratio22.9
ROE16.40%
ROA5.78%
Debt/Equity67.14
P/B Ratio3.4
Op. Cash FlowCN¥-2060471808
Free Cash FlowCN¥-526336512
Industry P/E31.4
Technical Analysis
TrendNeutral
RSI43.3
SupportCN¥66.86
ResistanceCN¥92.45
MA 20CN¥78.77
MA 50CN¥85.28
MA 200CN¥68.05
MACDBullish
VolumeStable
Fear & Greed Index91.46
Valuation
Target PriceCN¥121.51
Upside/Downside59.72%
GradeUndervalued
TypeBlend
Dividend Yield0.47%
Risk Assessment
Beta-0.08
Volatility54.84%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.